Kura Oncology: Poised For A Lift With Combinations [Seeking Alpha]
KURA Stock Rallies 8% on Strong Preliminary Renal Cancer Study Data [Yahoo! Finance]
How The Kura Oncology (KURA) Narrative Is Shifting With Komzifti Launch And New Analyst Targets [Yahoo! Finance]
Kura Oncology, Inc. (KURA) Discusses Updated Data on Darlifarnib and Cabozantinib Combination in Advanced Renal Cell Carcinoma Transcript [Seeking Alpha]
Kura Oncology Shares Surge Following Positive Kidney Cancer Trial Data [TheStreet.com]